ChloroquineV1, Main, Exploration, bibRecord, 001946

Inorganic pharmaceuticals

Identifieur interne : 001946 ( Main/Exploration ); précédent : 001945; suivant : 001947

Inorganic pharmaceuticals

Auteurs : Lamaryet Moody [États-Unis] ; Alvin A. Holder [États-Unis]

Source :

Annual Reports Section "A" (Inorganic Chemistry) [ 0260-1818 ] ; 2008.

RBID : ISTEX:F5E3A1C8974AD70E2B194EC790AF6EE88610B073

English descriptors

Teeft :
- Annu, Bactericidal action, Biochem, Biol, Biological activity, Bismuth, Bone density disorders, Boron, Boron concentration, Boron neutron, Calf thymus, Cancer treatment, Carborane clusters, Cell growth, Characterised, Chem, Chemotherapeutic agents, Chromium niacinate, Cisplatin, Cleavage activity, Coiii complexes, Commun, Contrast agent, Contrast agents, Coordination chemistry, Cytotoxic, Cytotoxic activity, Dalton, Dalton trans, Diabetes mellitus, Diabetic rats, Drug discovery, Elemental analysis, Escherichia coli, Favourable candidates, Gadolinium, Growth period, Higher activity, Human cancer cell lines, Imaging, Inorg, Inorganic pharmaceuticals, Insulin resistance, Ligand, Light irradiation, Lipid peroxidation, Magnetic resonance, Manganese polyoxometallates, Metal complexes, Mitochondrial cell death pathway, Monkey kidney epithelial, Nutritional biochemistry, Oxidative stress, Polyhedron, Potential contrast agents, Prog, Remarkable enhancement, Resonance imaging, Royal society, Sect, Silicone matrices, Supramolecular complexes, Tetrahedron lett, Thymus, Trans, Tumour, Viscosity measurements, Vivo studies, Wang, Wistar rats.

Abstract

This chapter reviews the literature reported during 2007 on some important advances in the area of inorganic pharmaceuticals. Research highlights for the respective metals during the year are also given.

Url:

https://api.istex.fr/ark:/67375/QHD-KWG9ZNDZ-1/fulltext.pdf

DOI: 10.1039/b716590k

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 002C76
to stream Istex, to step Curation: 002C76
to stream Istex, to step Checkpoint: 000851
to stream Main, to step Merge: 001954
to stream Main, to step Curation: 001946

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Inorganic pharmaceuticals</title>
<author wicri:is="90%"><name sortKey="Moody, Lamaryet" sort="Moody, Lamaryet" uniqKey="Moody L" first="Lamaryet" last="Moody">Lamaryet Moody</name>
</author>
<author wicri:is="90%"><name sortKey="Holder, Alvin A" sort="Holder, Alvin A" uniqKey="Holder A" first="Alvin A." last="Holder">Alvin A. Holder</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F5E3A1C8974AD70E2B194EC790AF6EE88610B073</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1039/b716590k</idno>
<idno type="url">https://api.istex.fr/ark:/67375/QHD-KWG9ZNDZ-1/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002C76</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002C76</idno>
<idno type="wicri:Area/Istex/Curation">002C76</idno>
<idno type="wicri:Area/Istex/Checkpoint">000851</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000851</idno>
<idno type="wicri:Area/Main/Merge">001954</idno>
<idno type="wicri:Area/Main/Curation">001946</idno>
<idno type="wicri:Area/Main/Exploration">001946</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Inorganic pharmaceuticals</title>
<author wicri:is="90%"><name sortKey="Moody, Lamaryet" sort="Moody, Lamaryet" uniqKey="Moody L" first="Lamaryet" last="Moody">Lamaryet Moody</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry and Biochemistry, The University of Southern Mississippi, 39406-0001, 118 College Drive, # 5043, Hattiesburg, Mississippi</wicri:regionArea>
<placeName><region type="state">État du Mississippi</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
<author wicri:is="90%"><name sortKey="Holder, Alvin A" sort="Holder, Alvin A" uniqKey="Holder A" first="Alvin A." last="Holder">Alvin A. Holder</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry and Biochemistry, The University of Southern Mississippi, 39406-0001, 118 College Drive, # 5043, Hattiesburg, Mississippi</wicri:regionArea>
<placeName><region type="state">État du Mississippi</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Annual Reports Section "A" (Inorganic Chemistry)</title>
<title level="j" type="abbrev">Annu. Rep. Prog. Chem., Sect. A: Inorg. Chem.</title>
<idno type="ISSN">0260-1818</idno>
<idno type="eISSN">1460-4760</idno>
<imprint><publisher>The Royal Society of Chemistry.</publisher>
<date type="published" when="2008">2008</date>
<biblScope unit="volume">104</biblScope>
<biblScope unit="issue">Advance Articles</biblScope>
<biblScope unit="page" from="477">477</biblScope>
<biblScope unit="page" to="497">497</biblScope>
</imprint>
<idno type="ISSN">0260-1818</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0260-1818</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Annu</term>
<term>Bactericidal action</term>
<term>Biochem</term>
<term>Biol</term>
<term>Biological activity</term>
<term>Bismuth</term>
<term>Bone density disorders</term>
<term>Boron</term>
<term>Boron concentration</term>
<term>Boron neutron</term>
<term>Calf thymus</term>
<term>Cancer treatment</term>
<term>Carborane clusters</term>
<term>Cell growth</term>
<term>Characterised</term>
<term>Chem</term>
<term>Chemotherapeutic agents</term>
<term>Chromium niacinate</term>
<term>Cisplatin</term>
<term>Cleavage activity</term>
<term>Coiii complexes</term>
<term>Commun</term>
<term>Contrast agent</term>
<term>Contrast agents</term>
<term>Coordination chemistry</term>
<term>Cytotoxic</term>
<term>Cytotoxic activity</term>
<term>Dalton</term>
<term>Dalton trans</term>
<term>Diabetes mellitus</term>
<term>Diabetic rats</term>
<term>Drug discovery</term>
<term>Elemental analysis</term>
<term>Escherichia coli</term>
<term>Favourable candidates</term>
<term>Gadolinium</term>
<term>Growth period</term>
<term>Higher activity</term>
<term>Human cancer cell lines</term>
<term>Imaging</term>
<term>Inorg</term>
<term>Inorganic pharmaceuticals</term>
<term>Insulin resistance</term>
<term>Ligand</term>
<term>Light irradiation</term>
<term>Lipid peroxidation</term>
<term>Magnetic resonance</term>
<term>Manganese polyoxometallates</term>
<term>Metal complexes</term>
<term>Mitochondrial cell death pathway</term>
<term>Monkey kidney epithelial</term>
<term>Nutritional biochemistry</term>
<term>Oxidative stress</term>
<term>Polyhedron</term>
<term>Potential contrast agents</term>
<term>Prog</term>
<term>Remarkable enhancement</term>
<term>Resonance imaging</term>
<term>Royal society</term>
<term>Sect</term>
<term>Silicone matrices</term>
<term>Supramolecular complexes</term>
<term>Tetrahedron lett</term>
<term>Thymus</term>
<term>Trans</term>
<term>Tumour</term>
<term>Viscosity measurements</term>
<term>Vivo studies</term>
<term>Wang</term>
<term>Wistar rats</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">This chapter reviews the literature reported during 2007 on some important advances in the area of inorganic pharmaceuticals. Research highlights for the respective metals during the year are also given.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>État du Mississippi</li>
</region>
</list>
<tree><country name="États-Unis"><region name="État du Mississippi"><name sortKey="Moody, Lamaryet" sort="Moody, Lamaryet" uniqKey="Moody L" first="Lamaryet" last="Moody">Lamaryet Moody</name>
</region>
<name sortKey="Holder, Alvin A" sort="Holder, Alvin A" uniqKey="Holder A" first="Alvin A." last="Holder">Alvin A. Holder</name>
<name sortKey="Holder, Alvin A" sort="Holder, Alvin A" uniqKey="Holder A" first="Alvin A." last="Holder">Alvin A. Holder</name>
<name sortKey="Moody, Lamaryet" sort="Moody, Lamaryet" uniqKey="Moody L" first="Lamaryet" last="Moody">Lamaryet Moody</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001946 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001946 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F5E3A1C8974AD70E2B194EC790AF6EE88610B073
   |texte=   Inorganic pharmaceuticals
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

Inorganic pharmaceuticals

Inorganic pharmaceuticals

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri